SUDBURY, ONTARIO: Verv Technologies (Verv) is pleased to announce John Simmons as Chair of the Board, effective December 1, 2023.
Mr. Simmons has extensive Board leadership experience and an exceptional track record in executive roles across the Canadian, U.S. and international healthcare sectors. Simmons brings decades of success in leading transformations of large teams, building businesses from the ground up and forming strong relationships with customers, industry groups, stakeholders, external partners and international affiliates.
“This is a key step in the evolution of our company,” says Jeff Sutton, Verv founder, board member and Chief Technology Officer. “We are thrilled to have John as Board Chair and will greatly benefit from his decades of experience leading worldwide business units aligned with our vision for Verv.”
Simmons was the former President (Canada), Becton Dickinson (BD); President (Canada), KCI Medical (now part of 3M); General Manager (Canada), Abbott Diagnostics; CEO of AceAge and held senior roles with Philips Healthcare and Johnson & Johnson.
Mr. Simmons has served on a number of Boards and is currently a Board Director at Southlake Regional Health Centre. Previously, Simmons served as the Chair of the Board of Directors of Medtech Canada.
“John’s incredible depth will help inform critical strategy as we transform Verv from R&D into rapid commercialization of products over the next year,” said Martin Gurbin, Verv CEO.“Verv sees a global opportunity given the challenges with access to care so many people have across the world. With John’s global experience, he will help us make a difference.”
About Verv: Verv is finalizing the development of the first portable, affordable, high- quality blood analyzer and is building a catalogue of disposable tests that will measure a wide range of analytes (cholesterol, vitamin levels, hormones). We were founded on the ability to separate blood plasma from a few drops of whole blood, without the need for expensive equipment. An affordable, accurate, easy-to-use device that can trend and share blood-testing data has significant potential to help monitor a person’s health status from their home.
VP Business Development